*Study also randomized patients (n=416) to a 240 mg TID arm. TID dosing resulted in no additional benefit over 240 mg BID.2
†Study also randomized patients (n=345) to a 240 mg TID arm. TID dosing resulted in no additional benefit over 240 mg BID.2
‡Disease activity: any change in relapse frequency, MRI activity, and/or disability progression.